[ET Net News Agency, 7 October 2024] JXR (01951) rose 9.6% to HK$4.32.
It hits an intra-day high of HK$4.35, hitting a 52-week high, and an intra-day low of
HK$4.05. The total shares traded was 27.26 million, with a value of HK$113.87m. The active
buy/sell ratio is 59:41, with net buying turnover of HK$19.12m. MORGAN STANLEY HK SEC
accounts for greatest net responsive buying turnover of HK$5.48m, with volume weighted
average price of HK$4.172. BARCLAYS CAPITAL ASIA accounts for greatest net responsive
selling turnover of HK$8.92m, with volume weighted average price of HK$4.184. The stock
has risen a combined 19.3% over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 4.320 % Chg +9.64%
High 4.350 Low 4.050
Shares Tr 27.26m Turnover 113.87m
10-D SMA 3.262 %H.V 83.324
20-D SMA 2.740 VWAP 4.177
50-D SMA 2.576 RSI14 85.366
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 59:41, with net buying turnover
of HK$19.12m, rising a combined 19.3% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
JXR (01951) 4.32 +9.64
GENSCRIPT BIO (01548) 14.38 -2.04
INNOVENT BIO (01801) 48.85 -4.50
EVEREST MED-B (01952) 28.85 +6.65
WUXI BIO (02269) 22.70 +5.83
WUXI APPTEC (02359) 69.50 +3.58
BEIGENE (06160) 150.50 +0.80
CANSINOBIO (06185) 32.45 +0.93
AKESO (09926) 70.95 -4.64
INNOCARE (09969) 7.28 +5.97
---------------------------------------------
(ed)